AA
AlphaCentric Advisors’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-117,500
| Closed | -$3.36M | – | 237 |
|
|
2024
Q2 | $3.36M | Hold |
117,500
| – | – | 2.48% | 6 |
|
|
2024
Q1 | $3.43M | Hold |
117,500
| – | – | 2.07% | 5 |
|
|
2023
Q4 | $3.96M | Buy |
117,500
+14,500
| +14% | +$489K | 2.66% | 4 |
|
|
2023
Q3 | $3.16M | Buy |
103,000
+46,500
| +82% | +$1.43M | 1.79% | 10 |
|
|
2023
Q2 | $2.26M | Buy |
56,500
+20,500
| +57% | +$821K | 1.26% | 18 |
|
|
2023
Q1 | $1.47M | Buy |
36,000
+17,000
| +89% | +$694K | 1.01% | 24 |
|
|
2022
Q4 | $734K | Buy |
+19,000
| New | +$734K | 0.72% | 50 |
|